Dr Dainis Krievins is a Director of Institute of Research and Chief of Endovascular Program at Pauls Stradins Clinical university hospital. He has been a board-certified vascular surgeon since 1998.
Dr Krievins serves as the President of the Latvian Society of Vascular Surgery since 2012 and he is a Professor of Vascular Surgery at University of Latvia. In addition, he is co-founder and Executive Chairman of Scientific Advisory Board of Clinical Research Foundation EEU.
Dr Krievins’ special interest has been development of new vascular devices. He served as a principal investigator for numerous FIM and CE mark/FDA clinical trials. His academic research focuses on the process of innovation for development of novel medical technologies to treat aneurysms and peripheral arteries.
Dr Krievins graduated in 1993 from the Medical Academy of Latvia and he completed his residency of Surgery and Vacular Surgery at Riga Stradins University. He completed Vascular Surgery Fellowship at Stanford University Medical Center.
Dr Mastracci is a vascular surgeon with an interest in complex aortic repair. She completed general and vascular surgery training at McMaster University in Hamilton, Ontario, Canada, and moved on to a superfellowship in complex aortic repair at the Cleveland Clinic in Cleveland, Ohio. Dr Mastracci’s first consultant position was at the Cleveland Clinic, where she also held a position as assistant professor at Case Western Reserve University for seven years. Dr Mastracci moved to the Royal Free London in October 2014 to lead the aortic team.
Dr Mastracci is a clinical epidemiologist by training and focuses most of her research in clinical outcomes related to disease of the aorta. She has a specific interest in endovascular aneurysm repair, stent graft design and development, the genetics of aortic disease, and the advancement of new intraoperative imaging techniques. Recently Dr Mastracci has partnered with the radiation physics department at the Royal Free Hospital to improve radiation safety in the field of vascular surgery.
Ross Milner, M.D., is a board-certified general and vascular surgeon and Professor of Surgery at The University of Chicago. In addition, he is the Vice-Chair of Clinical and Peri-operative services and serves as Co-Directory for the Centre of Aortic Diseases. He is an internationally recognized expert in the treatment of complex aortic aneurysmal disease and endograft surveillance paradigms and has been a leader in training other physicians in these areas. Dr. Milner graduated cum laude from the University of Pennsylvania, Philadelphia, where he also completed medical school. He completed a general surgery residency, chief residency, and a fellowship in vascular and endovascular surgery at Hospital of the University of Pennsylvania. As the Marco Polo Fellow of the Society for Vascular Surgery at University Medical Center in Utrecht, the Netherlands, Dr. Milner investigated the value of remote pressure sensing for EVAR surveillance. Before joining the faculty at the Pritzker School of Medicine in 2012, Dr. Milner served at Emory University School of Medicine, Atlanta, Georgia; and at Loyola University Chicago’s Stritch School of Medicine, Illinois. Dr. Milner has been the primary investigator on numerous endovascular device trials and currently serves as the co-national principal investigator for the GREAT registry. He has authored more than 75 peer-reviewed journal articles and abstracts and many book chapters.
A frequent speaker, Dr. Milner has delivered invited lectures at more than 200 conferences and symposia in North and South America, Europe, and Asia.
A dedicated educator and mentor, Dr. Milner teaches medical students, residents, and fellows about vascular disease management, including the use of aortic stents. He has received numerous awards for his teaching and has been recognized as the first master clinician of the Bucksbaum Institute for Clinical Excellence at the University of Chicago. He is also a reviewer for many journals and is an editorial board member for Endovascular Today and Vascular Disease Management.
Dr Peter Schneider received his degree from the Johns Hopkins University School of Medicine in Baltimore, Maryland. He completed his internship, residency, and fellowship at the University of California San Francisco (UCSF) Medical Center as well as a fellowship at the Scripps Clinic and Research Foundation in La Jolla, California. At the Hawaii Permanente Medical Group (HPMG), Dr Schneider is the chief of the division of vascular therapy and Director of New Ventures. In recent years, he has served as co-chair of the organizing committee of the 9th Hawaii Vascular Symposium, and he moderated a session on peripheral vascular disease at the UCSF Vascular Symposium. At the Vascular Interventional Advances conference in Las Vegas, Dr Schneider was part of a team of HPMG vascular surgeons that performed cases via satellite for conference attendees. They had the privilege to share best practices for the care of patients with vascular disease, and to highlight the quality care Hawaii has to offer. The HPMG group started a fellowship for doctors from other hospitals to improve their skills in minimally invasive vascular repair. They have a very busy clinical research program with several clinical trials going on at once. The HPMG group publishes two to four scientific research articles per year. Dr Schneider has also published a textbook in vascular surgery which is widely used in the U.S. and abroad. He serves on the editorial board of Vascular Disease Management, Annals of Vascular Surgery, and Endovascular Today. In recent years, he has been a visiting professor at Beijing University, the University of Massachusetts Medical Center, the University of British Columbia, Oregon Health Sciences University, University of Kansas (McEwen Visiting Professorship), Boston University School of Medicine, Stanford University School of Medicine, and elsewhere. Dr Schneider is board certified in vascular surgery by the American Board of Surgery, and a fellow of the American College of Surgeons, the Society for Vascular Surgery, and the International Society of Vascular Surgery. He is a member of the Western Vascular Society, the Society for Clinical Vascular Surgery, the American Heart Association, the International Society for Endovascular Specialists, the Nafzigger Surgical Society, and the Johns Hopkins Medical and Surgical Association. Dr Schneider enjoys being involved in the community in his free time. He was on the board of directors of Network Enterprises, a non-profit corporation that employs handicapped workers, and has also served as their Vice Chairman.
Giovanni B. Torsello M.D. is Professor of Surgery. Since 1996 Chief of the Department of Vascular Surgery, St. Franziskus – Hospital, Muenster, and since 2008 Director of the Clinic of Vascular and Endovascular Surgery at the University of Muenster. He graduated from the University of Perugia, Italy 1977, completed his residency at the University Hospital, Duesseldorf, Germany 1995, awarded with Professorship at the University of Duesseldorf 1995. Prof. Torsello is an international respected teacher, researcher and international lecturer. He has authored or coauthored more than 300 articles in prestigious medical journals and is an expert in the treatment of vascular and endovascular diseases. He is Director of the German Vascular Academy and Past president of the German Vascular Society. Particular fields of scientific and medical interest: Treatment of complex disease of the thoracic and abdominal aorta and of the renal and visceral arteries. Treatment of the “diabetic foot”, minimally invasive treatment of venous disease.